Pursuant to Regulation 30 of SEBI (LODR) Regulation 2025 there is change in directors of board MS. Babita (DIN: 09064124) Non Executive & Independent Director of the Company has reisgned ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare Ltd has informed the BSE that Ms. Babita (DIN: 09064124), a Non-Executive & Independent Director on the company's board, has resigned with effect from January 24, 2026. She cited personal reasons and unavoidable circumstances for her departure. The company confirmed that she has stated there are no other material reasons behind her exit beyond what was disclosed. Ms. Babita also serves as an independent director on Space Incubatrics Technologies Limited. The resignation has been signed off by Umesh Kumar, Additional Director of the company.
This is a single independent director exit for personal reasons, with no governance red flags mentioned. It may marginally affect board composition but is unlikely to have a material impact on the stock, as the company has confirmed no undisclosed material concerns.